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A.  Introduction 
A. 1  Epidemiology  
 
Infection is one of the major problems in the medical care of neonates. 
Throughout the world, 30 million infants contract an infection in the neonatal period, 
and 1 - 2 million of these die (1;2). Although most of these deaths take place in 
developing countries, where neonatal mortality from sepsis may be as high as 60%, 
even in the developed world the incidence of neonatal infection is still of 1.1 - 2.7 % 
of all live births (3). These numbers may vary from country to country, from nursery to 
nursery and have been changing over the years. 
The relative immunodeficient state of neonates taken together with the increasing 
survival of progressively more premature infants contribute to the high mortality and 
morbidity associated with neonatal infection (1). Sepsis may affect up to 16 % of low 
birth weight infants (501-1500g) in the neonatal intensive care unit with a mortality 
rate of 15 - 50% (4;5). 
 One of the most common challenges in newborn medicine is the diagnosis of 
infection. The early diagnosis of neonatal infection based on the clinical criteria alone 
is difficult and laboratory values might lag. Yet rapid progression of untreated 
infection may greatly increase morbidity or mortality. 
The incidence of early onset sepsis has diminished in the past years due to 
intrapartum antibiotic prophylaxis, whereas the incidence of late onset sepsis has 
increased. This is due to the better survival of very low birth weight infants who need 
considerable mechanical and nutritional support and remain hospitalized for long 
periods (6-8).  
 
A. 2  Definitions and Classification of Neonatal Infection 
 
There is no uniform definition of neonatal infection or sepsis, mainly since blood 
cultures are not very frequently positive.  
For this study we used the definitions resulted from the International Sepsis 
Definitions Conference 2001(9) and the International Pediatric Sepsis Consensus 
Conference 2005 (10;11) 
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Infection 
The International Pediatric Sepsis Consensus Conference in 2005, defined 
infection as: “A suspected or proven (by positive culture, tissue stain, or polymerase 
chain reaction test) infection caused by any pathogen OR a clinical syndrome 
associated with a high probability of infection‖ (10). Evidence of infection includes 
positive findings on clinical exam, imaging, or laboratory tests (e.g., white blood cells 
in a normally sterile body fluid, chest radiograph consistent with pneumonia, petechial 
or purpuric rash, or purpura fulminans). 
The symptoms that result from these infections may be caused by a wide variety 
of bacterial and viral pathogens, but their clinical manifestations are very similar (1). 
 
Sepsis 
The International Sepsis Definitions Conference 2001 defined sepsis as ―a 
systemic inflammatory response syndrome (SIRS) in presence of a suspected or 
proven infection‖ (9). This definition was later accepted for pediatric cases (10;11). A 
bloodstream infection during the first month of life is called neonatal sepsis. 
 
Severe sepsis 
Severe sepsis is defined as sepsis plus one of the following: cardiovascular organ 
dysfunction or acute respiratory distress syndrome or two or more other organ 
dysfunctions (10).  
 
Septic shock 
Septic shock is a sepsis that causes cardiovascular organ dysfunction (10) 
resulting in hypotension despite adequate fluid resuscitation (12). 
 
Severe bacterial infections can also be classified as early- and late-onset sepsis. 
 
Early-onset sepsis 
Early-onset sepsis (EOS) can be acquired through vertical transmission by 
ascension from the lower genital tract of the mother, through transplacental 
transmission after maternal bacteremia or by passage through the birth canal. Early-
onset sepsis becomes clinically evident within the first few days of life, and has been 
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defined in most reports as occurring within the first week or the first 72 hours of life 
(6;13-15). 
 
Late-onset sepsis 
Late-onset sepsis (LOS) presents thereafter, with an upper limit of the 28th, 30th 
or 90th day of life (6). ―Late-onset infections may be acquired intrapartum during the 
passage through the birth canal, through horizontal spread within the hospital 
settings, or from maternal or other sources in the home or community‖ (13). 
 
A. 3  Risk Factors for Neonatal Infection 
 
Several factors such as maternal, environmental, and host factors determine 
which infants exposed to potentially pathogenic organisms will develop invasive 
bacterial infections. The presence of any of the following factors can be associated 
with a 10-fold or greater increased risk of developing systemic infection (5): 
 Chorioamnionitis as evidenced by intrapartum fever (core temperature of ≥ 
38ºC before delivery), uterine tenderness, maternal leucocytosis (White Blood 
Cells ≥ 18000 leukocytes /µl) or elevated C-reactive protein (≥ 1mg /dl). Infants 
born to mothers with chorioamnionitis have a sepsis incidence of 1-5% (16) 
Odds Ratio (OR) = 6.43 (17). 
 Prolonged rupture of membranes (PROM) ≥ 18 hours before delivery, OR = 64 
(17). After delivery 3 - 5% these infants will present with an infection (3). 
 Stained amniotic fluid (3) 
 Preterm delivery OR = 4.83 (17)  
 Maternal Group B Streptococcus (GBS) colonization at delivery: OR = 204; 
Light colonization: OR = 97.1; Heavy colonization: OR = 247 (17) 
 Previous infant with invasive GBS (18)  
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A. 4  Microbiology of Neonatal Infections  
 
The agents responsible for early-onset sepsis are mostly those found in the 
maternal birth canal (5). The incidence of these pathogens has varied over the past 
60 years. Before the introduction of the sulfonamides and penicillin in the 1940s, 
gram-positive cocci, particularly group A streptococci, were responsible for most 
cases of neonatal sepsis (16). After the introduction of antimicrobial agents, gram-
negative enterics, in particular E. coli, were predominant causes of serious bacterial 
infections of the newborn. An increase in serious neonatal infection caused by group 
B streptococci was noted in the early 1970s. Since then, Streptococcus agalactiae or 
B ranks as leading cause of early-onset sepsis followed by E. coli in the United 
States and Western Europe. Despite universal screening for B Streptococcus this 
has not changed. In developing countries S. aureus and gram-negative bacilli, 
specially Klebsiella are the most common isolated agents (6;8;13;19) (tab. 1).  
 
 
 
Typical Early-onset Pathogens and its Predominance 
  
 Group B streptococci (GBS): 1.3-3.7 per 1000 live births (1). 
 E. coli: 1 per 1000 live births (1) (5) (18). 
 S. aureus 
 Klebsiellen 
 Enterocci 
 Other Streptocci  
 Lysteria monozytogenes 
 Anaerobic Bacteria (Bacteroides fragilis) 
 
Table A.1: Early onset pathogens in neonatal infections 
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A. 5  Pathogenesis of Neonatal Infection 
 
Pathogens can be transmitted from mother to fetus by diverse modes (EOS, 
LOS). The state of development of the immune system of the newborn plays a key 
role in neonatal infections.  
 
A. 5. 1 Ways of Acquiring an Early Onset Infection 
 
The developing fetus is protected from the microbial flora of the maternal genital 
tract. Before labor and membrane rupture, amniotic fluid is nearly always sterile (8). 
Initial colonization of the newborn and of the placenta usually occurs after rupture of 
maternal membranes. If delivery is delayed after membranes rupture, the vaginal 
micro flora may ascend and in some cases produce inflammation of fetal 
membranes, umbilical cord and placenta. Fetal infection may also result from 
aspiration of infected amniotic fluid. Even if delivery follows shortly after rupture of the 
membranes, the infant may be colonized during passage through the birth canal (5).  
Before rupture of fetal membranes, organisms in the genital tract may invade the 
amniotic fluid and produce infection of the fetus. These organisms can invade the 
fetus through microscopic defects in the membranes, particularly in devitalized areas 
overlying the cervical os (19). A usual route by which the fetus may become infected 
is the transplacental spread after maternal infection and invasion of the blood stream.  
 
 
Figure A.1: Ways of acquiring infection in the fetus. The fetus is shown inside the uterus. 
Uterus and Vagina are shown in red. The branching arrow represents the transplancental 
spread of bacteria. The ascending arrow represents the ascending infection from the vagina. 
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Initial colonization of skin and mucosal surfaces of the newborn infant include the 
nasopahrynx, oropharynx, conjunctivae, umbilical cord and external genitalia. In most 
infants the organisms proliferate at these sites without causing symptoms. Few 
infants become infected by direct extension from the sites of colonization (e.g., 
sinusitis and otitis from nasopharyngeal colonization). Alternatively, invasion of the 
bloodstream may ensue, with subsequent dissemination of infection. The umbilical 
cord is a particularly common portal of entry for systemic infection because 
devitalizated tissues are an excellent medium for bacterial growth and because the 
recently thrombosed umbilical vessels provide direct access to the bloodstream 
(5;19). 
 
A. 5.2  The Immune System of the Newborn  
 
The susceptibility of the neonate to a wide variety of microbes results from 
limitations of both innate and adaptive (antigen-specific) immunity (20). During the 
second half of pregnancy the fetus develops the ability of cellular and humoral 
defense. However, the immune system is inhibited to avoid reject-reactions between 
mother and fetus. The adaptation of the immune system takes place after birth. 
Hence, immune effector-systems are less powerful in newborn and especially in 
preterm infants as in adult (21) There are also deficiencies in processes through 
which the innate immune system facilitates and directs the development of protective 
antigen-specific immunity. For example, neonatal serum has been shown to be 
inefficient in killing E. coli because of a deficiency of non-immunoglobulin G serum 
components (6). Many parts of the defense system are relatively immature in the 
healthy neonate. 
 
The particular differences in the immune system of newborns compared to adults 
are: 
  T cells that help for B cell differentiation have an impaired function with a 
decreased cytokine production and delayed antigen-specific responses of CD4+ 
T cell. The ability to stimulate B cells is also decreased (21). 
  B cells and immunoglobulin. The newborn is protected from infection by 
passive IgG antibodies, predominantly transferred during the latter third of 
pregnancy. Fetal IgG concentrations are equal or higher than maternal 
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concentrations after 34 weeks of gestation. The lacking ability of the neonate to 
produce antibodies in response to polysaccharides, limits its defense against 
bacterial pathogens to which the mother has developed little or no IgG 
antibodies. The antibody response to new antigens is delayed but it improves 
rapidly after birth (5;8). On the other side IgM antibodies are deficient in the 
newborn. B-lymphocytes transport on their surface polyreactive IgM antibodies 
with a low affinity to specific antigens (21). This may explain its susceptibility to 
gram-negative infections (22).  
  Natural killer cells in neonates are decreased in number and activity 
against their target cells, including virus-infected target cells, compared with 
adult (8). 
  Phagocytes, whose deficiencies include a reduced adhesiveness with 
impairment of chemotaxis and motility of polymorph nuclear cells (PMNs) and 
mononuclear phagocytes as well as a diminished neutrophil storage pool (20). 
Tissue macrophages from neonate animals have a reduced phagocytic and 
microbicidal activity. 
  Humoral mediators of inflammation and opsonization. Neonates have 
moderately diminished alternative and classic component pathway activity and 
decreased in some terminal complement components. Fibronectin is also lower 
(8). Cytokine production is deficient and may be responsible for the decreased 
inflammatory response seen in newborns (22). Thus, neonatal sera are less 
effective in antibody-independent opsonization when concentrations of antibody 
are low. These deficiencies contribute to delayed inflammatory responses and 
impaired bacterial clearance (5). 
 
A. 5.3 The Neonatal Inflammatory Response 
 
―Despite similar clinical presentations, the molecular and cellular processes 
that elicit the sepsis response differ depending on whether the organism is gram-
negative, gram-positive, fungal, or viral in nature. The sepsis response to a 
gram-negative organism is provoked by the release of lipopolysaccharide (LPS), 
an endotoxin from within the cell wall of the gram-negative bacteria, which is 
released during lysis. Gram-positive, fungal, and viral organisms, however, 
initiate a sepsis response that begins with the release of exotoxins and cellular 
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antigenic components‖ (23). Both responses trigger the sepsis cascade, which 
begins with the release of primary inflammatory mediators such as tumor 
necrosis factor and interleukin-1β. This initial step in the cascade of events will 
lead to inflammation and tissue destruction. Once bacteria cross the mucosal 
epithelium and enter the tissues, phagocytes and opsonins become the critical 
elements of defense. Antibody and complement opsonize the bacteria for 
phagocytosis and killing by neutrophils and macrophages (5). 
 
 
Figure A.2: Endothelium and inflammatory response. The platelets (green bodies), 
endothelial cells (purple), macrophages (light blue cell with dark centers), polymorphonuclear 
cells (pink with 3 inner lobes) and cytokines (small pellets) are inflammatory mediators (24). 
 
The absence of type-specific antibodies and the subtle but cumulative deficits of 
other host defense mechanisms contribute probably to the neonate susceptibility to 
infection (8). Limitations in the production of chemotactic factors or reduced 
chemotactic responses of neonatal neutrophils, may end in delayed response of 
neutrophils to sites of infection. Secondarily, neonatal neutrophils may kill bacteria 
less efficiently due to reduced amounts of opsonins or because the local bacterial 
density has reached high levels. Severe infections can deplete the limited marrow 
neutrophil reserve and worsen the problem (8). 
Despite lack of type-specific antibodies and a multitude of subtle deficits in 
neonatal defenses, relative few infants acquire infections (5). 
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A. 6  Diagnosis of neonatal infection 
 
Early diagnosis of neonatal bloodstream infection remains one of the biggest 
challenges to neonatologists. It might be based on pregnancy history and certain risk 
factors might raise suspicion. Observation of clinical signs, laboratory tests and 
particularly the intuition and clinical experience help the neonatologist to establish the 
diagnosis of infection (4). 
 
Clinical signs 
The newborn infant responds to harmful stimuli with limited stereotyped reactions 
(8). As a result clinical signs of bacterial infection in the neonate are inexplicit and 
may be associated with infectious or with non-infectious disorders. The presence of 
any of these signs alone or in combination is an indication for complete evaluation to 
rule out sepsis. Any neonate who is not doing well, without an ostensible reason, is a 
priori suspect of infection (25). The major signs and symptoms of infection relate to: 
 
 Abnormalities of temperature regulation in the form of hyperthermia, or less 
commonly, hypothermia. 
 Respiratory distress manifested as tachypnea, grunting respirations, cyanosis, 
intercostals and substernal retractions, and apnea. 
 Hemodynamic signs like tachycardia (> 180 beats/min) or bradycardia (< 100 
beats/min), hypotension, capillary refill time > 3 seconds, gray skin color. 
 Gastrointestinal findings, including poor feeding, weak suck, regurgitation, 
vomiting. 
 Neurological deficiencies evidenced as diminished awareness, lethargy, tonus 
abnormalities, irritability and seizures. 
 Cutaneous findings: Purpura, eruptions.  
 
Clinical manifestations of the group B streptococcal early-onset syndrome may be 
present at birth or may appear at any time within the first 72 hours of life. For E. coli 
infections the start is typically after 2-3 days (3). Onset can be sudden and followed 
by a fulminant course, with the primary focus of inflammation in the lungs.  
The diagnosis of neonatal infection is difficult to establish based on the clinical 
criteria alone and the results of microbiological isolates from sterile body fluids need 
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at least 3 days to be obtained. Therefore clinicians have to rely on laboratory tests to 
rule out an early onset infection (26). 
 
Laboratory tests 
Complete blood counts and white blood cell ratios: Total leukocyte and 
neutrophil count, total non-segmented neutrophil count and neutrophil ratios are 
neither specific nor sensitive for the diagnosis of neonatal infection (5;25). Ottolini et 
al. reported a sensitivitiy of 41% and a specificity of 73 % in diagnosing neonatal 
infection by abnormal values of white blood cell (WBC) count. 
 
Acute-phase reactants: C - reactive protein (CRP). CRP is a hepatic protein 
produced within the 6 - 8 hours as part of an immediate inflammatory response to 
infection or tissue damage. The acute-phase-response is effective in the newborn. 
CRP concentration is elevated in umbilical cord blood and in newborns blood after 
bacterial and fungal infections (27). Its increase in plasma is due to inflammatory 
cytokines such as Interleukin 6 (27). 
Acute infections caused by gram negative pathogens as enterococci cause a 
strong increase in CRP. The bacterial endotoxin stimulates directly the macrophages 
(CRP > 100mg /l).  
Acute infections caused by gram positive bacteria, parasites and fungi cause a 
moderate increase in CRP (CRP < 100mg/l). On the other side, virus, like Adenovirus 
cause no or just light CRP increase (CRP < 30mg/l) (28). 
With appropiate antibiotic therapy, CRP will decrease (15;29). As it does not cross 
the placenta, CRP is an excellent marker for neonatal bacterial infection; however, it 
is not useful for early diagnosis. The increase in CRP response to neonatal bacterial 
infection occurs about 12 – 36 h after the onset of clinical signs. The sensitivity at the 
beginning of sepsis is only 60 % (29). Therefore, a negative CRP at the initial 
evaluation does not rule out serious infection, whereas a positive CRP suggests that 
more than 12 – 36 h have elapsed since the onset of the inflammatory response (26). 
CRP can be considered as a ―specific‖ but ―late‖ marker of neonatal infection. False 
positives can be due to meconial aspiration, fetal asphyxia, shock, cerebral 
hemorrhages, tissue necrosis and recent vaccination such as Hepatits B (29-31). 
CRP is also a good parameter to evaluate the efficacy of the therapy (27). 
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Proinflammatory cytokines such as Interleukin 6 (IL-6), Interleukin 8 (IL-8) 
and tumor necrosis factor-α are increased in serum 1 – 2 h after exposure to 
bacterial products and precede the increase in CRP. A number of studies reported a 
cytokine overproduction from the umbilical cord cells when exposed to endotoxines. 
Cytokines such as the interleukins IL-1β, IL-6, and IL-8 and TNF-α are endogenous 
mediators of the immune response to inflammation including that caused by bacterial 
infections. IL-6 is involved in many aspects of the immune response. It is elevated in 
the presence of chorioamnionitis and delivery room intubation, yet depressed in the 
presence of pregnancy-induced hypertension. Several studies suggest that elevated 
levels of IL-6 detected after birth may provide an early and sensitive parameter for 
the diagnosis of neonatal bacterial infection. IL-8 is predominantly produced by 
monocytes, macrophages and endothelial cells. Its kinetics are similar to those from 
IL-6 (26). However, ―because of variations in study design and methodology, 
estimates of diagnostic sensitivity and specificity for IL-6 and IL-8 levels range from 
60% to greater than 95% for each one‖ (8). 
 
Procalcitonin (PCT): is one of the calcitonin precursors. Its release is stimulated 
by microbial infections. Monocytes and hepatic cells are believed to be the 
producers. Serum concentrations of PCT begin to rise 4 h after exposure to bacterial 
endotoxins, peak at 6-8 h, and remain raised for at least 24 h (29). Unfortunately, 
false positives have also been found in neonates with respiratory distress syndrome, 
intracranial hemorrhage, pneumothorax, severe trauma and hemodynamic failure 
without having a bacterial infection. The value of PCT as an early marker for bacterial 
infection is also complicated by a physiological increase of procalcitonin during the 
first days of life. However, Chiesa and colleagues (32) studied the accuracy of IL-6, 
CRP and PCT in all perinatal events and concluded that the ―physiological‖ increase 
is relative small when compared to the magnitude of PCT response to bacterial 
infection. Both the sensitivity and specificity of PCT were greater than those of CRP 
and IL-6. 
Procalcitonin may be an important valuable marker for the detection of early 
neonatal infection when reference values, the clinical condition, and the 
administration of antibiotics are taken into account (29;30).  
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A. 7  Treatment of neonatal infection 
 
Successful management of neonatal bacterial sepsis depends on early diagnosis 
and prompt initiation of appropriate antimicrobial therapy and supportive measures. If 
untreated, infections in newborns can rapidly become severe and life-threatening.  
If the physician considers a newborn to be septic, cultures should be obtained and 
treatment with antibiotics be started immediately. Currently, the drugs most frequently 
used and recommended to treat suspected severe neonatal infections, in both 
developed and developing countries are a combination of penicillin or ampicillin and 
aminoglycosides (usually gentamicin) (5;33). 
In general, initial therapy must include coverage for gram-positive cocci, 
particularly group B streptococci and gram-negative enteric bacilli. Penicillin is the 
choice for gram-positive cocci. Choice for therapy for gram-negative infections 
depends on the current pattern of antibiotic susceptibility in the local hospital. Most 
experts prefer ampicillin and gentamicin for therapy of presumptive sepsis and 
ampicillin and cefotaxime for presumptive bacterial meningitis (19). 
Combining two or more antibiotics is the usual clinical practice when initiating 
therapy for presumed systemic bacterial disease (e.g., ampicillin and aminoglycoside 
are combined to treat suspected early-onset septicemia or meningitis before 
identification of the pathogen). After a bacterium has been identified and its 
susceptibility to various antimicrobials is determined, the most appropriate drug or 
drugs should be selected (16). 
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A. 8   Microcirculation 
A. 8. 1  Definition 
 
The term microcirculation concerns the blood flow through blood vessels smaller 
than 100 µm (i.e. arterioles, capillaries and venules). The most purposeful function of 
the circulation occurs in the microcirculation, specifically in the capillaries (6-12µm). 
The biggest part of interchange of nutrients and cellular excreta between circulating 
blood and tissue cells takes place here. The microcirculation of each organ is 
organized specifically to ensure adequate oxygen and nutrients delivery to meet the 
demands of every cell. The typical arrangement of the capillary bed is not found in all 
parts of the body; however, some similar arrangement serves for the same purposes. 
 
 
Figure A.3: Schematic drawing of a capillary bed. Red colored vessels contain arterial, violet 
mixed and blue vessels contain venous blood. Arrows indicate the direction of the blood flow. 
The capillary network is the site of OPS measurements. 
 
The local conditions of the tissues can cause direct effect on the vessels in 
controlling local blood flow and metabolic demand in each tissue area thanks to the 
metarterioles and precapillary sphincters (34;35). 
 
A. 8.2  Blood supply in the epidermis of newborns 
 
At birth, the blood supply of the skin shows relative little variation. It is richly 
supplied by a dense subepidermal plexus, samples of which look more or less the 
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same wherever they are examined. Middle and deep dermis are richly endowed with 
vasculature (36).  
The mature pattern of capillary loops and of the subpapillary venous plexus is not 
present at birth but develops as a result of the absorption of vessels at some sites 
and capillary budding with migration of endothelium at other sites. Several studies 
have observed the morphology changes of capillaries during the first weeks of life. 
Perera et al. (37) investigated the changes that take place in the upper dermis 
obtaining the following results: 
- At birth the skin shows no papillary loops except for the palms, soles and nail 
folds. At the same time skin shows a disorderly capillary network. 
- By the end of the first week of life the capillary network assumes a more orderly 
network pattern and papillary loops begin to appear as a small superficial dilatations 
or buds in the second week. 
- Defined loops begin in the 4th or 5th week in at least one area of the skin but are 
observed over all in the 14th to 17th week. The development of order with a distinct 
horizontal plexus is a gradual process, first apparent during the second week but it is 
not characteristic of all areas until the 14th to 17th week. The development of an 
orderly sub papillary plexus and papillary loops is greatly delayed in skin creases 
(Fig.A.4). 
 
Figure A.4: Development of Microvascular skin perfusion from Perera et al. (37). It 
demostrates how capillary loops develop over time and in this process the capillary network 
becomes more organized and less abundant. 
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Other investigators have suggested that a mature pattern depended more on the 
weight of the child than on the time since birth. The microvasculature of the skin 
continues to develop during the first 3 months of life with some areas being faster 
than others. Several investigators have suggested that it may be due to cold and 
blood stasis in those areas (36). 
 
 
A. 8. 3  Techniques to Observe the Microcirculation in vivo 
 
Since the microcirculation plays a critical role in many disease states, such as 
diabetes, hypertension and sepsis, knowledge of its structure and function in humans 
is of great importance (38). 
The direct observation of the microcirculation in disease has long been the aim of 
many scientists. Investigation on the capillary circulation began soon after the 
microscope came into use. Malpighi, for example, observed blood flow in the 
mesentery and bladder of the frog in 1686. Most of the observations were made on 
animals and upon translucent tissues. In 1874, Hueter by means of reflected light 
observed the vessels on the inner border of the lower lip, calling his method 
cheiloangioskopie. Weiss standardized in 1916 a method for the observation of the 
skin capillaries at the ends of the fingers and toes (39).  
 
Laser Doppler Fluxometry (LDF) 
In LDF monochromatic laser light is emitted into the tissue and scattered back 
giving an enlarged signal which is process to a linear output. LDF uses the Doppler 
shift to give a value of the mean erythrocyte flux found in the investigated tissue. Is 
very easy to apply and requires few minutes to obtain readings (40). 
The electromagnetic waves from the laser light are emitted into the tissue. The 
reflected parts are captured with a photo-detector. When the light hits an object in 
movement the frequency changes which produces the ―Doppler-effect‖. 
 
Intravital microscopy 
Intravital microscopy allows visualizing the interaction of blood components with 
the endothelium (e.g. leucocytes and thrombocytes) and the leakage of 
macromolecules into the tissue. Intravital microscopy usually requires a fluorescent 
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dye to enhance contrast which has restricted its use primary to animal experiments 
(40). Measurements of the human microcirculation can be made through the capillary 
nailfold bed without the use of fluorescent dyes, but its value may be limited by the 
extreme sensitivity of nailfold microcirculation to external temperature or 
vasoconstrictive agents. The capillary microscopy setup consists of an intravital 
microscope, which restricts its use in humans to the skin and other easy accessible 
sites like the lip and the bulbar conjunctiva (41). Applications in perioperative and 
intensive care have not yet entered into routine due to the awkward handling of the 
devices and the limited number of vascular beds that can be visualized (40).  
 
 
Figure A.5: Image of mouse cremaster muscle: without (left) and with (right) fluorescent dye 
using intravital microscopy (42). 
 
 
 
 
Figure A.6: Nail fold capillary microscopy (43). 
 
Orthogonal Polarisation Spectral (OPS) imaging 
OPS imaging was invented while developing a video microscope to obtain high 
contrast images of blood in the microcirculation using reflected light. It offers clinically 
relevant perspectives since it allows an easy and portable access to a variety of 
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vascular beds without the need of dyes for contrast enhancement (40). This makes 
also an applicability on organ surfaces possible, where not only capillaries but also 
complete microcirculatory networks can be studied (41). 
OPS imaging makes the direct observation of the microcirculation in real time 
possible.  
Several validation studies comparing OPS imaging against standard intravital 
fluorescence microscopy in animal models (38;44;45) have demonstrated that it is 
possible to make quantitative measurements of relevant parameters (vessel 
diameter, red blood cell velocity and functional capillary density) from these images. 
Further studies have also showed a possible microcirculation monitoring at the 
patient bedside using semi-quantitative analysis of the images (46-48). For more 
details see B.3. 
 
Sidestream Dark-field (SDF) imaging 
It is an actual improvement of OPS imaging that also allows a microcirculatory 
bed side monitoring.  
SDF imaging consists of a light guide (Fig. 3), surrounded by 530nm light-emitting 
diodes (LEDs), a wavelength of light that is absorbed by the haemoglobin of red 
blood cells, allowing their observation as dark cells flowing in the microcirculation. 
The LEDs at the tip of the guide are optically isolated from the inner image-
conducting core, and pump light deep into the tissue, illuminating the microcirculation 
from within. 
 
 
Figure A.7: Sidestream Dark-field imaging (49). This image shows the principals of SDF 
technique. Green light is emitted via LEDs. Only scattered light is detected by the camera 
after passing through a magnifying lens. 
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This dark-field illumination applied from the side completely avoids tissue surface 
reflections, giving clear images of microcirculatory structures and red, as well as 
white, blood cell flow. A magnifying lens projects the image onto a video camera. It is 
expected that SDF imaging will improve the imaging modality for the microcirculation, 
especially for capillaries (50). Until then, validation and comparative studies need yet 
to be done.  
 
A. 8. 4 Microcirculation Dysfunction and Sepsis  
 
Microcirculatory dysfunction during sepsis is characterized by heterogeneous 
abnormalities in blood flow with some capillaries being underperfused, while others 
have normal to abnormally high blood flow (49;51;52). 
An intact and correctly functioning microcirculatory system is essential for efficient 
tissue oxygen delivery, yet, in sepsis, mediators of the inflammatory response impair 
microcirculatory function. The precise mechanisms involved remain to be elucidated. 
They include (53): 
- a reduction in the number of perfused capillaries (so-called reduced functional 
capillary density), 
- reduced red blood cell (RBC) deformability. Microvascular RBC flow is 
passively distributed throughout the capillary networks according to local 
vessel resistance (diameter and length) and hemorheologic factors (blood 
viscosity and RBC deformability).During sepsis the mechanical properties of 
the RBC, including membrane deformability and shape recovery are 
progressively altered such that the RBC becomes less deformable (54). 
- endothelial cell dysfunction with increased permeability and apoptosis. Injury 
to the endothelium due to primary inflammatory mediators release results in 
expression of adhesion molecules on the cell surface which produce increased 
rolling, strong adherence, and transmigration of leukocytes into underlying 
tissue. Activated endothelial cells attract platelets, monocytes, and neutrophils 
- cells that are capable of initiating or amplifying coagulation. Thus, damaged 
endothelium induces a net procoaulant phenotype with the result of 
microthrombi formation and impaired fibrinolysis (12;23).  
- altered vasomotor tone as consequence of activated endothelium. 
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- increased number of activated neutrophils with more neutrophil - endothelial 
interactions due to increased endothelial expression of surface adhesion 
molecules and release of inflammatory cytokines. 
- activation of the clotting cascade with fibrin deposition. Inflammation and 
coagulation are closely linked in sepsis. In response to microbial invasion, 
macrophages release primary inflammatory mediators that results in the 
activation of the coagulation system and the complement system (23). 
Inflammatory mediators generate tissue factor expression and initiate 
coagulation through activation of the extrinsic pathway. This results in 
increased coagulation, and simultaneous depression of the inhibitory 
mechanisms of coagulation, and suppression of the fibrinolytic system results 
in a procoagulant state that may lead to the formation of microvascular trombi 
(55). The formation of thrombin from activated coagulation stimulates the 
activation of proinflammatory mediators. Thrombin has multiple effects on 
inflammation and also helps to maintain the balance between coagulation and 
fibrinolysis. Thrombin has a proinflammatory effect on endothelial cells, 
macrophages, and monocytes, resulting in the release of TF, platelet 
activating factor, and TNF-α. The cytokine response contributes to platelet 
activation and aggregation (23). 
 
Even in the absence of sepsis, newborns and premature infants have a 
predisposition toward hypercoagulation. Neonatal plasma concentration of protein C 
and protein S is reduced. During sepsis, this hypercoagulability is further exacerbated 
by decreasing amounts of inhibiting coagulation factors (antithrombin (AT), protein C, 
protein S, reduced thrombomodulin, plus inhibition of fibrinolysis by plasminogen 
activator inhibitor-1 (PAI-1)) (23). 
The clinical presentation is similar to adults; hypercoagulability leads to a 
prothrombotic state with resulting organ dysfunction (23). 
It has been demonstrated that microcirculation plays an important role in the 
pathogenesis of shock and organ dysfunction, especially in sepsis (49). The 
introduction of orthogonal polarization spectral imaging allowed the first clinical 
observation of the microcirculation in human internal organs under the state of sepsis 
and septic shock. Recent studies using this technique have demonstrated the crucial 
role of microcirculatory abnormalities in defining the severity of sepsis and predicting 
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its outcome, a condition not revealed by systemic hemodynamic or oxygen-derived 
variables (46;48;53). 
De Backer et al. investigated the sublingual microcirculation by 50 patients with 
severe sepsis using orthogonal polarization spectral imaging. They observed reduced 
vascular density and a smaller proportion of perfused small (< 20 µm) vessels in 
septic patients compared to control patients (52). Sakr et al. monitored the 
microcirculation on a group of 49 patients suffering from septic shock from the onset 
of septic shock until its resolution. They concluded that microcirculatory alterations 
improve rapidly in septic shock survivors but not in patients dying with multiple organ 
failure (46). 
Based on these observations we hypothesized that similar changes should be 
seen in term neonates. 
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B. Goals of the dissertation 
 
 
1) Primary question:  
Are there changes in microcirculation of the skin very early in infection in term 
newborns? 
 
2) Secondary questions:  
1. What is the ideal site to observe non-invasively the microcirculation with OPS in 
term infants?  
2. How to reduce movement or pressure artifacts of the images 
3. Adapt the image analysis to the images obtained in neonates  
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C.  Material and Methods 
 
C.1  Study Design and Study Group 
 
The microcirculation was observed prospectively on newborns on their 1st, 2nd 
and 3rd day of life after parental consent. No blood samples were taken due to the 
study. The investigator was blinded to clinical status and laboratory parameters of the 
infants. Microcirculation of the skin was analyzed in all newborns that fulfilled the 
inclusion criteria (see below).  
 
Newborns were excluded according to the exclusion criteria (see below). 
 
General Inclusion criteria 
 Birth weight > 1500g. 
 Gestational age between 36 and 41 weeks. 
 Age < 12 hours at the first measurement 
 Written consent from the parents (see addendum (G)). 
 
Inclusion criteria for the control group 
 No risk factors for infection (see A.3) 
 Repeated clinical examination without pathological findings. 
 Normothermia. 
 APGAR-score ≥ 8 at 1st, 5th or 10th minute. 
 CRP values ≤ 0.5 mg / dL on the 3 first days of life. 
 
Inclusion criteria for the study group: “neonatal infection risk” 
 Rupture of fetal membranes > 18 hours 
 Maternal fever (> 38,5ºC) 
 Elevation of maternal C-reactive Protein 
 Fetal Tachycardia 
 Stained amniotic fluid 
 Lethargy or diminished awareness without a peripartal infection risk 
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Exclusion criteria 
 Congenital defect of cardiovascular system, urogenital system, central 
nervous system, lungs, gastrointestinal system and skin. 
 Congenital TORCH- infection 
 Anemia (Hct <35%) 
 Polycythemia (Hct >65%) 
 Phototherapy 
 Severe perinatal asphyxia 
 Chromosomal anomaly 
 Missing of parental consent 
 
C. 2  Diagnosis of Infection 
 
C. 2. 1  Clinical Evaluation 
 
On the 1st and 3rd day of life a paediatrician obtained a physical exam of the 
neonates. Nurses examined the newborns several times a day and if something 
abnormal was seen, the physician was immediately informed. Clinical signs for 
infection are described in detail in A.6. 
 
C. 2. 2  Laboratory Testing 
 
In case of suspect findings on the physical exam or risk factors for infection in the 
maternal history, blood samples were obtained. Total blood counts as well as CRP 
and IL-6 were measured. This is part of the routine care for all infants. If CRP and IL-
6 levels were below 0.5mg/dl and below 50pg/ml respectively, and the clinical status 
of the infant remained well, no more blood samples were obtained. If the infant 
continued to have positive clinical signs or laboratory tests for infection, CRP values 
were controlled during the next days. 
Infection was defined as clinical suspicion in combination with increased C-
reactive protein (>0.5 mg /dL) and/or increased IL-6 (>50 pg /mL) during at least one 
of the 3 days. Elevated CRP and IL-6 serum levels lead to the assignment into the 
infection group. An elevated IL-6 alone without any elevation of the CRP values 
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during the next days was considered false positive (29;56) and the infant was 
assigned to the control group. 
 
IL-6 and CRP were analyzed in all infants with signs or risks for infection on the 
first day of life. If both were negative and the clinical status of the infant remained 
good no more blood samples were taken. If the infant began or continued to have 
clinical signs of infection and/or IL-6 was positive, CRP was controlled during the next 
days. 
 
C - reactive protein: It was quantitatively determined through a turbidimetric 
immune test using the Olympus System CRP Latex- Reagent. The system can 
measure CRP down to very low concentrations. 
Interleukin 6 was calculated with the IL-6 EASIA-CB assay in the laboratories of 
the department for clinical chemistry, Klinikum Grosshadern. The IL-6- EASIA-CB is a 
solid phase Enzyme Amplified Sensitivity Immunoassay (EASIA) performed with 
beads. The assay is based on a sandwich assay in which monoclonal antibodies 
directed against distinct epitopes of IL-6 are used. The minimum Detectable 
Concentration is estimated to be 1, 5 pg/ml.  
 
C. 2. 3  Microbiological Testing 
 
Blood culture  
When by the clinical history or symptoms or laboratory findings, an infection was 
suspected, a blood sample for bacterial culture was taken. The quantity of the sample 
was at least 1 ml and was sent for aerobic culture to bacteriology department of the 
Max-von-Pettenkofer Institute in Munich. 
 
Cerebrospinal fluid culture 
If infants appeared sick and the CRP level was above 2 mg /dl prior to antibiotic 
therapy, a spinal tap was performed and spinal fluid was sent for culture and 
laboratory exam. 
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C. 2. 4  Treatment 
 
In case of a presumed systemic bacterial infection the infant was treated 
intravenously for at least 3 days with antibiotics or until CRP values returned to 
normal levels (≤0.5 mg/dl). The infants received Ampicillin at a dose of 150 mg per 
kilogram body weight per day and Cefotaxim at a dose of 100 mg per kilogram body 
weight per day. When bacterial meningitis was suspected, the dosage was increased 
to 300 mg per kilogram body weight per day for Ampicilin and 200 mg per kilogram 
body weight per day for Cefotaxim. During treatment with antibiotics Nystatin 0.5 I.U. 
was given twice a day to prevent fungal superinfections.  
 
C. 3  Defining Infection and Group Assignment 
 
Infection was defined as elevated C-reactive protein (>0.5 mg /dL) with or without 
increased interleukine-6 (>50 pg /mL) during at least one of the 3 days of 
measurement. Elevated CRP levels lead to the assignment into the infection group. 
An elevated IL-6 alone without any elevation of the CRP values during the next days 
was considered false positive (29;56) and the infant was assigned in the control 
group. 
After discharge, prior to image analyzes, infants were classified as following: 
- Non Infected if CRP < 0.5 mg /dl during the 3 days of measurement. 
- Infected if CRP > 0.5mg /dl at least one of the 3 days of measurement. 
 
 
C. 4   Visualization of Microcirculation with Orthogonal 
Polarization Spectral (OPS) Imaging 
 
C. 4. 1  Technical background of OPS imaging 
 
To obtain images polarized incident light is projected through a beam splitter into 
the tissue. To image blood, a wavelength region, centred at an isosbestic point of 
oxy- and deoxyhemoglobin (548 nm), is chosen. Most of the superficially reflected 
light retains its polarization. In deeper layers of the tissue, a multiple scattering 
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occurs producing depolarized scattered light. A second orthogonally oriented 
polarizer is used to reject the light reflected from tissue surfaces with unchanged 
polarization before visualization. Thus, only light which has penetrated the tissue and 
has undergone scattering is depolarized and therefore detected. Scattered light 
works as a virtual source of light illuminating the objects from behind (fig. C.1) (57-
59).  
 
 
Figure C.1: Optical schematic of the OPS imaging probe adapted from Groener et al. (59). 
Polarized green light is sent via a polarizer and a beam splitter into the tissue. Two kinds of 
light are reflected. Polarized reflected light, which is absorbed by the analyzer, and 
depolarized scattered light, which is recorded by the CCD video camera 
 
C. 4. 2  Cytoscan® 
 
Cytoscan® is a small and portable handheld device which has OPS imaging 
technology incorporated (60) (fig. C.2.). 
 
  
Figure C.2: Cytoscan® A/R imaging device 
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For our study we used the Cytoscan® A/R (Cytometrics, Inc. Philadelphia, PA, 
USA). It is equipped with a mini-CCD (charged-coupled device) camera of 5 x 
objective (Costar CV-M536 CCIR, JAI, Japan) (see fig.C.2). The 5 x objective lens 
gives a magnification at the camera face of 1 µm per pixel with a field of view of 
approximately 0.7 mm x 0.8 mm.  
 
  
Figure C.3: Parts of the device: Probe (right), light source (metallic box) and CCD camera 
(black box). 
 
The main parts of the device are the base unit (left side) with a holster for the 
probe on the top of it. The probe (right) is connected to an external light source (left 
on top of the base unit) via a guide cable and emits green light of a wavelength of 
548nm during the measurement. The CCD camera connector cable (at the rear of the 
probe) is plugged into the base unit (fig. C.3). Via a PAL - Video recorder (Video 
Cassette Recorder, AG-7350, Panasonic, Osaka, Japan) and a monitor (PVM-1442 
QM diagonal 33cm Sony, Munich, Germany), online imaging as well as recording of 
the images could be performed (fig. C.4). Images were recorded in standard VHS - 
Videocassettes (FUJI E -240 and SONY 240 DXF).  
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Figure C.4: Measurement Set with Cytoscan
®
 devices and monitor on top, and video 
recorder underneath. 
 
C. 4.3  Development of a Holding Device to Fixate the Cytoscan® Probe 
 
During first test measurements it became increasingly clear, that it is very difficult 
to maintain the Cytoscan® camera device manually in a position which is stable 
enough to record good quality images. Due to magnification of the image, minimal 
movements of the hand resulted in wiggly sequences with pressure bias. In order to 
reliably evaluate the capillary microcirculation of a newborn, at least a few seconds of 
steady images are needed. Therefore it was necessary to develop a tool that would 
help to maintain the position of the Cytoscan® stable during the measurements. In 
collaboration with the department for technical assistance of the Frauenklinik 
Maistrasse we built a camera holding device with two aluminium bars and 2 
articulations. The new device helped to adjust the position of the camera. The use of 
this prototype immediately improved the image quality by helping to achieve a stabile 
camera position (fig. C.5).  
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The major disadvantage of the first prototype was its rigidity. To be able to react 
faster to the unpredictable movements of the newborn infants and to be able to 
adjust the camera position more accurate, we developed additional models of the 
camera holding device up to the actually used prototype (fig. C.6). It has a wide 
range of motion in three spatial dimensions, is stabile and very precisely adjustable. 
Additionally it is small enough to be used inside of incubators for measurements on 
premature infants. The holding device not only increases the quality of our images, it 
also reduces the time needed to study the microcirculation of infants from 
approximately 30 minutes to around 5 minutes. Especially in cases of restless 
newborns this is a substantial advantage. 
 
C. 4. 4  Optimal Site for OPS Measurements 
 
Based on the observations of Genzel-Boroviczèny and co-workers (61;62) the 
measurements were performed on the skin of the inner upper arm. The skin of term 
newborns is thicker than the skin of premature infants. This increased thickness 
leads to overall lower quality of the images. The light can not penetrate as deep into 
the tissue as it does in premature infants with their not yet finally developed skin. 
Additionally, the OPS recordings of term infants’ microcirculation show a smaller 
number of microvessels in the inner upper arm as compared to the recordings 
obtained from premature infants.  
Figure C.5: First holding Device for 
the Cytoscan® imaging probe. 
Figure C.6: Definitive holding Device for 
the Cytoscan® imaging probe. 
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Figure C.7: Differences between the images obtained on upper arm from a 
mature (left) and premature (right) infant. 
 
In the search for a better image recording area, measurements of virtually all 
areas of the skin of term newborns were done. We found that images obtained at the 
ear conch, had a better quality and showed a larger heterogeneity in microvessels 
than those obtained in inner arm. The ear conch is also free from lanugo and has a 
good vascularization. Finally, the newborns were not at all bothered by the 
measurement as the access is very easy and undressing is unnecessary (fig. C.8).  
 
 
Figure C.8: Obtaining OPS images from the ear conch. 
 
C. 4. 5  Duration of Measurements  
 
The infants were measured in a calm moment, usually when they were asleep or 
after breastfeeding. Thus, we tried to avoid movement artefacts caused by a restless 
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child and vascular changes caused by a possible increase of blood pressure, which 
was observable when the children were crying. To perform the measurements the 
infant was placed on a changing table at room temperature. The ear which was 
exposed was chosen for the measurement. Using the holding device (see C.4.3.), the 
Cytoscan probe was slowly lowered to the skin until an image appeared on the 
monitor. A drop of water was placed between the skin and the probe to enhance the 
quality of the images. Once the image on the monitor was focused, the recording of 
the sequences began. We attempted to obtain 10 sequences of 10 seconds of 
duration each on the ear conch. For each sequence a different capillary network was 
searched. The same procedure was used in the inner side of upper arm. Measure-
ments on the ear conch were performed on the first, second and third day of life.  
In general, the recording was finished after 20 minutes but it always depended on 
how quiet the infant was. If the infant began to get agitated the measurement was 
postponed till after the next breastfeeding. 
 
C. 4.6  Analysis of the OPS Sequences  
 
The videos obtained were recorded on VHS - Videocassettes. After digitalization 
and coding using the record function of CapiScope® computer Program (KK Techno-
logies, UK), the OPS sequences were analyzed off-line and blinded to clinical status 
of the infant. A six digit code was assigned to each infant to blind the observer to 
group assignment when evaluating the images. For the analysis a semi-quantitative 
method based on the works of De Backer (52) and Boerma (47) was used.  
For that purpose a grid with three equidistant horizontal and three equidistant 
vertical lines was drawn and placed on the monitor showing the image. Two different 
parameters were analyzed: 
 
Functional Vascular Density (FVD) 
 Analysis with a semi quantitative method  
The functional vascular density was calculated as the number of vessels crossing 
the lines on the grid placed over the image, divided by the total length of the lines. 
Vessels were identified by watching the recordings of the OPS measurements. In 
cases where an artefact such as hair, skin or water impeded the vision of the vessels 
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crossing a line, the length of this line was subtracted before dividing it by the total 
length of the line. 
 
 
Figure C.9: OPS image obtained at the ear conch of a term infant with grid. The red lines 
over the image represent the grid used for the semi quantitative method of FCD 
determination. 
 
 
 Quantitative analysis using the CapiScope® software 
To calculate the Functional Vascular Density (FVD) with CapiScope® we traced 
the perfused capillaries within a defined area. CapiScope® calculates the length of 
the marked capillaries and divides this by the area of observation. 
 
Figure C.10: Screenshot during FVD determination using the CapiScope® software. 
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Figure C.11: More detailed image of FVD determination via CapiScope®. 
 
Blood Flow analysis with a semi-quantitative method 
To determine the blood flow the researcher watched repeatedly the recordings of 
the OPS measurements. Similarly to the calculation of the FVD only capillaries that 
crossed the lines of the grid were evaluated. The evaluated vessels were divided into 
two groups according to their diameter. Small vessels were defined as vessels with a 
diameter < 20 µm and large vessels were defined as those with a diameter between 
20 – 100 µm. Vessels with a diameter larger than 100 µm were not seen.  
The type of intravascular blood flow was classified for each vessel as no flow, 
intermittent flow, sluggish flow and continuous flow. 
All vessels that did not have a continuous flow were classified as pathologic. The 
final read out of the analysis of the capillary blood flow was the percentage of vessels 
with a continuous flow.  
 
 
C.5  Statistical evaluation 
 
 The Mann Whitney U test was used to compare microcirculatory parameters of 
the 2 groups and Apgar score values.  
 T-Tests were performed to compare the clinical data of the groups. Values are 
given as mean ± standard deviation (SD) if parametric, otherwise as median with 
95% confindence interval (CI). Level of significance was set at p < 0.05. 
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Infants with 
infection 
Infants with no 
infection 
n= 10 
n = 8 
Newborns without risk 
factors for infection 
n = 29 
n= 8 
n = 21 
N = 16 N = 31 
Newborns with risk 
factors for infection  
n = 18 
D.   Results 
D. 1   Patient Data 
 
D.1.1  Characteristics of the Study Subjects 
A total 47 newborns were included into the study. Eighteen of the included infants 
were female (38%). 29 (62%) infants did not have any risk factor for an infection. Out 
of all infants, 16 (34%) developed an infection (Infection group) and the rest, 31 
(66%) newborns, remained well (No Infection group) (see fig.D.1). 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 Figure D.1: Study population and final assignment to the study groups 
 
 
 
Infection Group 
n = 16 
No Infection Group 
n = 31 
Number of newborns 16 (33%) 31 (67%) 
Sex 
Male 14 (87%) 15 (48%) 
Female 2 (13%)  16 (52%) 
Mean birth weight ± SD 
(gr.) 
3526± 490 3311± 456 
Mean gestational age ± SD 
(weeks) 
39.3± 1.2 38.9± 1.2 
 
Table D.1: Demographic data of the infants in both groups. 
 
No statistical differences were observed in birth weight and gestational age 
between both groups. However, the percentage of males was noticeably larger in the 
infection group (tab. D.1). 
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D.1. 2  Birth Modus and APGAR-score 
 
The types of birth included: spontaneous delivery, caesarean section, vacuum 
extraction and forceps extraction. In both groups the majority of infants were 
delivered spontaneously. There was no statistical significant difference on birth 
modus (tab. D.2). 
The APGAR-score of the infants was determined at the first, fifth and tenth 
minute of life as it is standard of care in the department of neonatology. The APGAR-
scores did not significantly differ between both groups (tab. D.3).  
The pH in the umbilical cord and the base excess (BE) in the umbilical cord were 
slightly lower in the infection group compared to the no infection group. This 
difference did not reach statistical significance (tab. D.3). 
 
 No Infection Infection 
Spontaneous Delivery 22 (68.7%) 7 (43.7%) 
Caesarean section  5 (15.6%) 5 (31.2%) 
Vacuum Extraction 3 (9.3%) 3 (18.7%) 
Forceps Extraction 1 (3.1%) 1 (6.2%) 
 Table D.2: Birth modus 
 
 
 No Infection Infection 
 
Median APGAR-
score  
1min 5min 10min 1min 5min 10min 
9  10 10 9 10 10 
Min. APGAR-score 7 10 10 7 10 10 
Max. APGAR-score 9 10 10 10 10 10 
pH in umbilical cord 
± SD 
7.32 ± 0.08 7.29± 0.09 
BE in umbilical cord 
± SD(mmol/L) -4.6 ± 3.19 -4.27 ± 3.7 
Table D.3: APGAR-scores and pH and BE in umbilical cord  
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D.1.3  Body Temperature 
 
The rectal temperature of the infants included in the study was measured daily by 
the nurses. The results of temperature measurements showed no statistical 
difference between the infants with infection and the infants without it (tab. D.4). 
 
 No Infection Infection 
1st day (mean ± SD) 37 ± 0.30 ºC 37 ± 0.49 ºC 
2nd day (mean ± SD) 37.1 ± 0.16 ºC 37.3 ± 0.37 ºC 
3rd day (mean ± SD) 37 ± 0.13 ºC 37 ± 0.13 ºC 
Table D.4: Rectal temperature in grades Celsius measured during the first 3 days of life. 
 
 
D.1.4  Clinical Symptoms for Infection 
 
Infants were seen daily and their clinical status assessed. Twelve of the 
newborns (38%) in the no infection group showed abnormal clinical symptoms 
including lethargy, problems with temperature homeostasis, capillary refill time being 
larger than 3 seconds and grunting respirations in the first day of life. None of these 
symptoms persisted on the following days (tab. D.5).  
In the infection group seven (44%) newborns showed clinical symptoms of 
infection during their first day of life. Two of the infants had an impaired temperature 
homeostasis on their second day of life. No pathological findings were reported for 
the third day of life (tab. D.5). 
 
 
No Infection Infection 
1st  2nd 3rd 1st 2nd 3rd  
Lethargy 2 0 0 1 0 0 
Problems with 
temperature regulation 
7 0 0 3 2 0 
Capillary refill time ≥ 3 
seconds 
2 0 0 2 0 0 
Grunting respirations 2 0 0 1 0 0 
 
Table D.5: Main clinical signs observed among the infants which could indicate 
infection. 
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 D.1.5  IL-6 Values 
 
IL-6 values were obtained from a total of 23 newborns in their first day of life 
because of suspected infection. From the infection group 8 out of 12 examined 
newborns had positive IL-6 values for an infection with a mean value of 507.3 pg /mL 
(fig. D.1) and a median of 99.6 pg /mL. 
In the no infection group, two from a total of 11 had positive IL-6 values for an 
infection. The IL-6 mean value of the no infection group was 32.5 pg /mL (fig. D.2). 
The median was 29.4 pg /mL. 
 
 
Figure D.2: Measurements of IL-6 obtained from the infection group on the first day of life. 
Each column indicates the IL-6 value of one individual patient. The dotted line indicates the 
limit for a positive IL-6 test 
 
D.1.6  CRP Values 
 
During the second day of life, in thirteen of the newborns CRP was analyzed. 
During the third day, in all infants of the infection group, and during the fourth day of 
life, in nine cases the levels of CRP were determined. The strongest increase of the 
CRP value was seen from the first to the second day of life. The majority of CRP 
serum levels declined after the second day, which was probably due to immediate 
start of antibiotic treatment (chapter C.2.4.). CRP levels were determined more than 
once in all infants in the infection group and in 2 infants in the no infection group. 
Figure D.3 shows the CRP serum levels of the infection group sorted by the 
43 
 
corresponding child. Most of the CRP serum levels are below 2 mg /dL. Few values 
show a dramatically elevated CRP indicating a severe infection (fig. D.3). 
 
 
Figure D.3: Course of CRP of the infection group sorted by individuals. The dotted line 
indicates the limit for a positive CRP test. The days of life are coded in colours. The CRP 
values are included in a table below, sorted by individual and day of life. 
 
D.1.7  Blood Pressure and Heart Rate 
 
For the majority of the included infants the blood pressure was measured. No sig-
nificant differences between the infection and the no infection group were found (tab. 
D.6). 
 No Infection Infection 
1st day 
n=21 
2ndday 
 n=11 
3rdday 
n=11 
1stday 
n= 9 
2ndday 
n= 6 
3rd day 
n=7 
Systolic blood 
pressure 
[mmHg] 
68± 9 69± 6 72± 8 69 ± 12 67± 6 65± 9 
Diastolic blood 
pressure 
[mmHg] 
40± 12 40± 7 41± 6 37± 8 40± 13 40± 7 
Mean blood 
pressure 
[mmHg] 
48± 6 48± 8 52± 6 47± 10 48± 10 48± 7 
Table D.6: Mean values and standard deviation of blood pressure 
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D.1.8  Therapy  
 
Thirteen infants out of the total of sixteen infants in the infection group (81.25%) 
and one infant (3.2%) out of the no infection group received treatment with antibiotics 
and Nystatin for three days. One of the newborns from the no infection group 
received prophylactic treatment due to long rupture of membranes, 62 hours, before 
delivery. Three out of the thirteen newborns with infection that received antibiotics, 
received a treatment for presumed bacterial meningitis for 5 days (see D.2.4.). Four 
newborns of the infection group did not receive antibiotic treatment despite increased 
CRP-values because parents refused any treatment. 
One of the children in the infection group was treated with tincture of opium for 6 
days for methadone withdrawal. One of the no infected newborns received a vaccine 
for Hepatitis B virus in its first day of life and another child from these group received 
calcium 10% orally due to low serum calcium levels 
 
D. 1.9  Microbiology Results 
 
A blood culture was obtained from all infants that received antibiotic treatment. 
None of them was positive. Two newborns had also a liquor culture, one of them was 
positive for Staphylococcus aureus. 
 
 
D. 2  Optimal Location for the OPS Measurement 
 
As described in C.4.4. the skin of term newborns is more developed, has more 
layers and therefore is thicker than the skin of premature infants. These 
circumstances made it necessary to find a, in regard to previous work (61;62), new 
location for OPS measurements in term newborns. Extensive searches lead finally to 
an optimally suited area, the ear conch (see C.4.4.) 
Figure D.4 shows an OPS image of an infant from the control group. The 
relatively thin skin at the ear conch and the superficial course of the capillaries 
enables an easy scanning and recording of sharp images of the capillary net. A wide 
variety of micro vessels with distinct diameters that are close up to a capillary 
network is seen. 
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 Besides the differences in the structure of the capillary bed, OPS images 
recorded at the upper arm of a term newborn from the no infection group, show a 
poorer quality than those obtained from ear conch. Capillaries are predominant and 
no arteriole or venule can be seen. White curtain or smears like artefacts, caused by 
the skin folds, or lanugo, appear frequently on the images of the arm. It is very 
difficult to achieve an image with a good quality over the full size of the image field 
(fig. D.6). 
 
 
 
Figure D.6: OPS image of the micro vessels of the upper arm of an infant from the control 
group. The curtain or smear like artefacts are caused by skin, the double contrasts are hair 
artefacts. 
 
Figure D.4: OPS image of the micro 
vessels of the ear conch of an infant from 
the control group. 
Figure D.5: OPS image of the micro 
vessels of the ear conch of an infant from 
the infection group. 
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The differences between recordings from ear and upper arm seem even more 
impressive, if images recorded at the upper arm and ear conch of an infant from the 
infection group are compared. Even on the non moving picture, in comparison to an 
image recorded from a healthy newborn, multiple gaps between the erythrocytes and 
the pronounced decrease in the number of visible vessels can be seen (figs. D.4 and 
D.5). On the images recorded from the upper arm of an infant from the infection 
group, the same findings like gaps between the erythrocytes in one capillary and 
decreased number of vessels can be observed, but the difference to the healthy 
control is far less pronounced (figs. D.6 and D.7). In the moving picture, gaps 
between erythrocytes can be observed as alterations in microvascular flow, such as 
no flow, sluggish flow, and intermediate flow. Decreased number of vessels 
represents a decrease in functional vascular density (see C.4.6). 
 
 
 
 
 
 
 
 
 
 
 
Figure D.7: OPS image of the micro vessels of the upper arm of an infant from the 
infection group. 
 
 
D.3  Microcirculation Parameters 
 
D.3.1  Microvascular Blood Flow 
 
The microvascular blood flow was recorded on the upper arm and ear conch for 
all infants on their first, second and third day of life as described in C.4.4.-5. The 
evaluation was performed as described in C.4.6. All kinds of flow that were not conti-
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nuous were rated as pathologic flow (see C.4.6). The percentage of vessels with con-
tinuous flow was significantly decreased in the infection group (p = 0.0003) (fig. D.8). 
We also compared the flow quality between both groups in small vessels 
(diameter ≤ 20 micrometers) and large vessels (diameter ≥ 20 micrometers). In each 
group the percentage of the total of vessels with normal flow was significantly (p < 
0.05) lower in the infection group compared to the no infection group. The proportion 
of normal flow in small vessels was 89 % in the no infection group whereas in the 
infection group was 66% (fig. D.9).  
Figure D.8: Comparison of continuous flow between the no infection (mean = 90% and 95% 
CI [87-94]) and the infection groups (68% [56-81]) in all vessels seen on images recorded at 
the ear conch. The difference is highly significant (p = 0.0003). 
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Figure D.9: Comparison of continuous flow between the no infection (89% [86-93]) and the 
infection groups (66% [53-78]) in small vessels seen on images recorded at the ear conch. 
The difference is highly significant (p = 0.0009). 
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These proportions were similar for the large vessels, with 70 % of continuous 
blood flow in the large vessels of the infection group and 92 % in the large vessels of 
the no infection group (fig. D.10). Hence, the quality of the bloodflow between Infec-
tion and Non Infection groups was significantly different for small and large vessels.  
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Figure D.10: Comparison of continuous flow between the no infection (92% [88-95] and the 
infection groups (70% [59-80)] in large vessels seen on images recorded at the ear conch. 
The difference is highly significant (p < 0.0001). 
 
Images obtained from the upper arm showed a similar trend towards a lower 
proportion of continuous flow in the infection group, but in these measurements no 
statistical significance was reached (fig. D.11).  
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Figure D.11: Comparison of continuous flow between the no infection (87% [83-90]) and the 
infection groups (82 % [75-88]) in all vessels seen on images recorded at the upper arm. No 
statistical significant difference between the groups. 
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D. 3. 2  Correlation between laboratory values and microcirculatory 
changes 
 
There was no correlation between CRP and /or IL-6 values with the degree of 
pathological microcirculatory flow.  
 
D. 3. 3  Functional Vascular Density (FVD) 
 
As described previously, the functional vascular density was determined by the 
number of vessels that crossed the lines of a superimposed grid divided by the total 
length of these lines (see C.4.6). Comparing the FVD of images recorded at the ear 
conch of newborns included in the no infection group to those of the infection group, 
a tendency to a lower FVD in the infection group was determined. However this 
difference did not reach statistical significance (fig. D.12). Evaluation of the pictures 
recorded at the upper arm showed a comparable tendency, which also lacked 
statistical significance (fig. D.13).  
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Figure D.12: Comparison of functional vascular density between the no infection (6.5 [6.2-
6.8] /mm) and the infection groups (5.9 [5.5-6.5] /mm) in all vessels seen on images recorded 
at the ear conch. No statistical difference was reached. 
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Figure D.13: Comparison of functional vascular density between the no infection (5.8 [5.5-
6.2] /mm) and the infection groups (5.5 [5.0-6.1] /mm) in all vessels seen on images recorded 
at the upper arm. There is no statistical significant difference between the groups. 
 
 
D. 3. 4  CapiScope® Program versus Semiquantitative method for 
quantifying Functional Vascular Density. 
 
To see if there was a correlation between the semi-quantitative method (grid) and 
the quantitative method (Capiscope® software) we selected scans from both groups 
of infants in which no artefacts were seen. A total of 42 scans were analyzed using 
both methods. Values were compared using the Pearson’s correlation coefficients. 
Results showed an extremely high correlation between both methods with a 
Spearman rank correlation coefficient of 0.64 (p < 0.0001) (fig. D.14). 
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Figure D.14: Correlation of the functional vascular density calculated using the semi-
quantitative method (grid) and the CapiScope® software. Independent calculation of FVD 
using both methods was performed. Dots represent the values obtained using the semi-
quantitative method (Y-axis) and the CapiScope programme (X-axis).  
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E.  Discussion 
 
E. 1  Defining and Diagnosing Infection  
 
There is no universal agreement on the definition for neonatal septicaemia and 
particularly a definition for neonatal infection with negative blood, urine or spinal fluid 
cultures is not well established. Therefore, finding a definition of infection for the 
study was a challenge. Positive blood and spinal fluid cultures are considered for 
adult and even older children the gold standard (4) in the diagnosis of bloodstream 
infections (11). However, cultures in newborns are often false negative, and therefore 
not useful as gold standard. They can be falsely sterile as suggested in post mortem 
cultures. In vivo blood cultures might be false negative due to the low yield caused by 
insufficient sample volumes (11) or intermittent or low-density bacteraemia due to 
inhibition of bacterial growth by earlier (i.e. intrapartum) antibiotic administration (63). 
In our unit just 1 mL of blood is sampled for blood culture. Fischer et al. estimated 
that if 1 ml of blood is sent for culture (in practice these volumes are often smaller), 
the sensitivity of this test is only between 30-40% whereas if 3 ml are sent for culture, 
the sensibility rises to 70-80% (64). With the low sensitivity of the test in neonates 
and the time required for final results, neonatologists do not rely on positive blood 
cultures for the diagnosis of infection or sepsis.  
In the presented study (probably due to the low sensitivity of blood cultures, small 
volume of blood submitted for culture and the frequent use of intrapartal 
administration of antibiotics to the mother to prevent infection) in just 1 infant spinal 
fluid culture was positive (representing 6.2 % in the infection group) and no positive 
blood cultures were found. Serial determinations of C-reactive Protein levels have 
been shown to be useful in the diagnostic evaluation of neonates with suspected 
infection (15;15;29;29;63;65;66).  
Neonatal infection was defined as a CRP serum level of more than 0.5 mg /dl 
with or without an IL-6 serum level > 50 pg /ml. Infants showing an elevated CRP 
were included into the infection group of the study (see C.2 and C.3). We were aware 
that this proceeding would most likely lead to an over diagnosis of infection and lead 
consequently to antibiotic treatment of infants with no infection. However, as this 
proceeding was applied in clinical practice, we also adopted it for the presented 
study. In 4 infants with presumed infection, microcirculation appeared normal with 
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more than 85% of the vessels with a continuous microcirculatory blood flow. These 
infants were described as clinically well without signs of infection and their CRP 
levels were between 0.62-2 mg/dl. 
 
 
E. 2 Patient population 
 
Male predominance in the infection group 
Interestingly, 80% of newborns with infection were male newborns. It has been 
previously described that male newborns are at higher risk for neonatal infections 
(67) although the cause of this is still unknown. Our data seem to confirm this 
elevated risk of male newborns for infection. 
 
 
E. 3 OPS Measurements 
 
Several validation studies comparing OPS imaging with standard intravital 
fluorescence microscopy in animal models have demonstrated that it is possible to 
make quantitative measurements of relevant parameters (vessel diameter, red blood 
cell velocity and functional capillary density) from these images (45;59). Further 
studies have also shown a possible microcirculation monitoring at patient bedside 
using semi-quantitative analysis of the images (46-48;52). The use of OPS in 
newborns has been already validated (61). 
OPS-imaging has some disadvantages. With this technique, only those tissues 
with a thin epithelial layer can be explored. The direct visualization or study of organs 
can only be made during surgery. The study of the microcirculation during infection in 
newborns can only be conducted on the skin. This does not allow the observation of 
changes occurring in central organs. Movement- or pressure- artefacts as well as the 
presence of blood, saliva or hair can affect the quality of the images obtained and 
thus the resultant data. Therefore, investigator movements or pressure were avoided 
by using a holding device for the microscan camera. Moreover, any type of dirt on the 
skin must be removed before the measurement. In our measurements the most 
frequently problem was the movement of the babies. The only possibility to obtain 
good quality images was to record only when the newborns were asleep which made 
sometimes the recordings time demanding. 
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E. 3. 1  Holding Device for OPS Measurements 
 
The quality of the images obtained with OPS is very sensitive to movement 
artefacts. For the evaluation of the microcirculatory status of an infant it is necessary 
to record sequences of at least 10 seconds duration without virtually moving the 
camera device. Stabile images of ten seconds duration are the basic requirements 
for off-line video analysis using CapiScope® (KK Technology, Colyton, Devon, UK). 
Up to a certain extent it is possible to stabilize the images with the automatic 
movement correction software tool of CapiScope®. Although this is very helpful for 
correcting small movements in the sequence, movements of wider amplitude may 
result hard and very often impossible to correct (68). 
In this context the development of the holding device for the camera was a major 
improvement for the image quality (see C.4.3). The holding device not only stabilized 
the image, but also reduced dramatically the time needed to achieve the sequences. 
This new invention has had a great impact on the overall image obtaining and 
evaluation quality.  
 
E. 3. 2  Applicability of OPS for Microcirculation Recordings in Term 
Infants 
 
The applicability of OPS in the study of the microcirculation in term newborns was 
essential for our experiments. Like in the studies performed on preterm infants 
(61;62) we can conclude that using OPS in newborns is possible (see D.2.). Until 
now, most of the studies done in humans have examined the microcirculation under 
the tongue (47;48;52;69) or in internal organs during surgery(44;70;71). We used the 
ear conch and the upper internal part of the arm as measuring points due to the fact 
that measurements under the tongue in term infants are not possible, since any 
object introduced in the mouth of a healthy newborn stimulates the sucking reflex.  
Previous studies in premature infants have used the inner arm as measurement 
location for OPS recordings (61;62). During our first assays in term infants we tried to 
assess the quality of the scans obtained in different body parts of term newborns. 
The result was the discovery of a new possible measure point, the ear conch. It has 
the great advantage of being an ease accessible location without the disadvantage of 
having to remove clothing. Thus, the baby is not disturbed and the scans can be 
easily obtained.  
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Life-threatening infections cause disturbances in the microcirculation of central 
organs reducing their blood perfusion and lead to organ failure and death (53). The 
ear conch is perfused by terminal branches of the external carotid artery and thus 
connected to central blood circulation. It can be hypothesized that alterations of per-
fusion observed at the ear conch are more relevant to the overall health status of the 
infant than changes of perfusion seen in the arm which resembles peripheral 
circulation.  
When comparing the results obtained in the study, we observed that the 
microcirculatory changes that can be seen during infection in newborns are easily 
recognizable in the scans from ear conch. In fact ear conch scans have some 
advantages over arm scans: 
- They are easier and faster to obtain (to get images of the arm we have no 
need to undress the baby). 
- The least pressure artefact is immediately noticed in the ear conch since the 
blood flow suddenly appears to be slower or even disappear. On the other 
side, the image quality of scans from arm appears to improve with slight 
pressure since more vessels are seen. This makes measurements at the arm 
more prone to bias caused by pressure (fig. E.1).  
- The ear conch is a very small area in newborns. Due to its size the 
measurements are all executed on virtually the same spot, which results in 
similar scans during the different measurement times. We have observed that 
the differences of scans obtained with just a centimetre of distance in inner 
arm can present extremely different capillary nets which result in very different 
data obtained from the same newborn during the same sets of measurements.  
 
 
Figure E.1: Images taken from the inner-upper arm from the same infant with (right) and 
without (left) pressure. Pictures were taken at the same point of measurement.  
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E. 4 Quantifying Microcirculatory Parameters with CapiScope® 
Software versus the Semiquantitative Method. 
 
Previous studies (61;62) in newborns have used the CapiScope®, a validated 
analysis software (72) to quantify microcirculation. It provides automatic red blood 
cell velocity measurements and calculates the capillary density. The program is very 
sensitive to low image quality and highly dependent on exact marking of central axis 
of the vessel. Especially the latter makes the image evaluation process extreme time-
consuming.  
The fact that the grid method correlates well with the CapiScope® calculated 
vascular density led us to accept the grid method as a reliable method to quantify the 
vessel density in microcirculatory scans. With the semi-quantitative method it is 
possible to determine most of the parameters involved in tissue perfusion, including 
vascular density and quality of perfusion. Reproducibility of the semi-quantitative 
score has been described by De Backer et al. as been very good, having an intra-
observer variability between 2.5 and 4.7 % for vessel density and 0.9 to 4.5% for 
vessel perfusion. The inter-observer variability is slightly higher (52). On the other 
side, it is not possible to determine the velocity of red blood cells as precisely as 
CapiScope® software does. 
 
 
E. 5  Microcirculatory changes in neonatal infection 
 
It has been shown that microcirculation is altered during infection 
(39;49;55;58;69;73). Studies in adults with sepsis have demonstrated that a 
pathological flow can be clearly observed in vivo with scans obtained using OPS and 
SDF image techniques (47;49;52;53;73). The impact of microcirculatory changes on 
the outcome of patients suffering from sepsis has been shown by Sakr et al. (46). 
Until now microcirculatory alterations during infection have never been observed in 
vivo on term newborns via OPS.  
The results obtained in the present work show, that OPS imaging is a helpful tool 
to observe and analyze microcirculatory changes in newborns with infection. From 
the total of 16 newborns of the infection group, 11 (69%) presented a pathological, 
not continuous, flow in more than 20 % of the vessels at least one of the three days 
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of measurements (see D.3.1). Previous studies in adults have shown such results on 
patients suffering from severe sepsis. None of our infants were severely septic. The 
highest CRP-value was 8.2 mg/dl which did not correlate with severe sepsis 
symptoms. There was no correlation to see between the degree of pathological 
microcirculation and the CRP value.  
The fact that microcirculatory changes could already be observed in situations of 
moderate infection can be explained taken into account: 
- the hypercoagulable state of the newborn infant (26)  
- and the overproduction of cytokines compared to adults which has been 
reported in several studies (74-76). 
 
In 4 of these 11 infants a pathological microcirculatory flow was detected at the 
same time as the CRP was elevated. These patients had elevated CRP levels 
already on the first day of life. In 6 neonates this pathological microcirculatory flow 
was even seen a day before the increase of CRP. 
An early initiation of antibiotic treatment is crucial for the outcome of newborns 
with infection and so is the need of tools that allow an early diagnosis of infection. 
The observations of this study indicate that OPS measurements might be a useful 
complementary tool helping to establish a diagnosis of infection in term newborns. 
The fact that half of the patients that developed microcirculatory alterations, showed 
these a day before laboratory changes were measurable, should lead to further 
investigation. Microcirculatory alterations seem to occur before CRP levels are 
increased in serum.  
 
Peculiar measurements in the infection group: 
Four infants (25%) in the infection group had a normal flow with < 20% of vessels 
with disturbed flow. Looking in detail into the data of these patients some possible 
explanations for these findings became apparent. 
-  Two of the four had only borderline elevated levels of CRP of 0.74 mg /dL and 
0.62 mg /dL, respectively. In these cases it might well be that they actually did not 
have an infection. Taking into account that almost all of the literature written 
about the sensitivity and sensibility of CRP in newborns is done with laboratory 
values of 1 mg /dL or above (15;32;65), this could be explained as false positives. 
Maybe this should lead to thinking about if the clinical practice is correct or if we 
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are being too cautious when considering a neonatal infection with CRP levels 
greater than 0.5 mg /dL.  
-  An additional case reached a CRP value of 2 mg /dL on the second day of life. 
The baby was born via caesarean section and so, had theoretically no traumatic 
delivery. Among the three days of measurements the child showed no clinical 
signs or symptoms for an infection. Could it be a false positive? No obvious 
explanation could be found to explain the CRP elevation in this case.  
-  The last of these four cases presented on the first day of life a CRP of 8.2 mg /dL 
together with signs and symptoms for an infection. Again the blood culture and 
the liquor puncture showed no growth. The microcirculatory changes observed in 
this infant where very interesting. Instead of the sluggish flow predominance, 
seen on the other infants, we observed a mixture of flows and a new one until 
now not observed. No flow or stagnant flow was seen in almost all capillaries with 
a smaller diameter than 10 μm. The rest showed a continuous flow or even a 
faster flow than usual. Probably the child had already entered in a hyperdynamic 
phase and due to the fact that we have defined pathologic flow as not continuous 
we missed this pathological finding. From this situation could be deduced that for 
following studies a ―hyper dynamic‖ flow should be included in the classification of 
flows for the semi-quantitative method.  
 
When comparing the microcirculation of this newborn with that of the only other 
newborn who reached high levels of CRP in blood (7.1 mg /dL), we saw a big 
difference. The second one presented a day before CRP reached its maximum, a 
pathologic flow in 82% of all its small vessels. From these differences arise further 
questions: 
- Are such microcirculatory differences due to the inter-individual inflammatory 
system responses? There are some studies which report a genetic 
polymorphism in bactericidal reactions of neonates which correlates with the 
severity and outcome of neonatal sepsis (77;78).  
- Is it due to the nature of the pathogen? Mohamed et al. (76) observed that the 
response of neonatal blood cells in secreting pro-inflammatory cytokines was 
different to different organisms. 
Probably both factors affect these changes on microcirculation. If the differences in 
these turn out to be secondary to the nature of the pathogen, one could speculate, 
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that OPS might get even stronger impact on helping in the diagnosis and treatment of 
neonatal infections in the future. However, these are only single observations and 
cannot take to definitive conclusions, but should be subject of investigation in larger 
scaled studies using OPS by neonatal infection. 
 
 
E. 6 Further Interesting Observations Using OPS 
 
OPS in dark pigmented children. 
At the beginning of the study we tried to observe the microcirculation in some 
black children. On their first day of life the images obtained could show the 
microcirculation but on the next days an overall melanin dots made these 
observations almost impossible. Melanin has a broad spectrum of absorption of 
wavelengths of 250 to 1200 nm which increases steadily toward shorter wavelengths 
(79). OPS light has a wavelength of 550 nm which is absorbed firstly by the melanin 
located in the epidermis. At the same level, the haemoglobin contained in blood 
vessels also absorbs this light. Thus, it is difficult to distinguish clearly the real path of 
the erythrocytes among the vessels and therefore the analysis of the microcirculation. 
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E. 7  Correlation between Laboratory Values and Microcirculatory 
Changes 
 
There was no correlation between the levels of elevated CRP and/or IL-6 values 
with the degree of pathological capillary perfusion. However microcirculatory flow was 
compromised in infants with elevated CRP levels. We hypothesize that the degree of 
altered perfusion correlates with the degree of organ damage caused by infection. 
Thus, microcirculatory changes show the direct effect of infection on tissue function. 
In contrast, CRP and IL-6 elevations are surrogate markers of inflammatory response 
as they do not resemble direct organ damage but a secondary immune response to 
infection. 
 
 
E. 8  Impact of these data 
 
The fact that changes on the microcirculation are easily observed on the ear 
conch of newborns suffering from a moderate infection may enable the use of OPS 
imaging as a complementary diagnostic or control tool in infections of newborn in the 
future. To make that possible the recruitment of more data and patients is needed to 
be able to analyse the results with enough statistical power.  
Further studies should also try to be able to solve the question if distinct pathogens 
show different changes in microcirculation blood flow and if the changes are reliably 
visible one day before laboratory testing becomes positive.  
Since different software tools are available to date, it might be even possible to 
develop an automatic evaluating tool in future, so that trained experts for the 
evaluation of the microcirculation of newborns, might become superfluous in future, 
which could, in case larger studies show a sensitivity and specificity for this test, lead 
to OPS as an easy bedside test for infection. 
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F.  Summary 
 
The early diagnosis of neonatal infection remains a challenge. Recent studies 
using Optical Polarized Spectral (OPS) imaging techniques, have reported 
microcirculatory alterations in adult patients with severe sepsis and septic shock. The 
objective of this study was to compare microcirculatory flow and vascular density 
between healthy controls and sick newborns with neonatal infection. 
OPS images were obtained prospectively from the vascular bed of ear conch and 
upper arm of 47 newborns on their 1st, 2nd and 3rd day of life. Infection was defined as 
IL-6 >50pg /mL and CRP >0,5 mg /dL. OPS sequences were analyzed off-line, 
blinded to clinical status of the infant with a semi-quantitative method based on the 
works of Sakr (46) and Boerma (47). Flow was examined differentiating between no 
flow, intermittent, sluggish and continuous flow. All vessels that did not have a 
continuous flow were classified as pathologic and their percentage was determined. 
Vascular density of the sequences was also calculated. 
Sixteen infants developed an infection. Most episodes of infection were not 
severe. Microcirculatory data was analyzed and tested with a non parametric test. 
The images obtained from ear showed a better image quality and an easier 
performance than those from upper arm in term newborns (infection: 32%, 95% 
confidence interval [19-44] vs. healthy: 10% [6-13]; p= 0.0003). Despite a tendency to 
higher percent of impaired flow, the microcirculatory flow in arm did not reach a 
statistical significance when comparing both groups (infection: 19% [16-25] vs. 
healthy: 13% [10-11]; p= non significant). A trend to lower vascular density was 
observed in the sequences obtained from ear in the infected group but not in those 
obtained from arm. Both places did not show a statistical difference. 
It can be concluded that ear conch is a better site to study the microcirculation in term 
newborns than the arm. In the ear conch even in infants with mild to moderate signs 
of infection, microcirculatory flow is impaired in a large proportion of vessels early in 
the course of disease. Since these changes can be easily recognized at the external 
ear, an on-line evaluation of microcirculatory flow could be an important screening 
tool for infection in the future.  
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G.  Zusammenfassung  
 
Die frühe Diagnostik neonataler Infektionen bleibt eine Herausforderung. Neue 
Studien mit Optical Polarized Spectral Imaging (OPS) haben bei Erwachsenen mit 
schwerer Sepsis und septischem Schock Veränderungen der Mikrozirkulation 
gezeigt. Das Ziel der präsentierten Arbeit war es den mikrozikulatorischen Blutfluss 
und die funktionale Gefäßdichte zwischen gesunden Neugeborenen und 
Neugeborenen, die an neonatalen Infektionen erkrankt waren, zu vergleichen. 
Die OPS Bilder wurden prospektiv an den subcutanen Gefäßbetten der Ohrmu-
schel und dem Oberarm von 47 Neugeborenen an ihrem ersten, zweiten und dritten 
Lebenstag aufgenommen. Infektionen wurden als IL-6 > 50 pg /mL und CRP > 0,5 
mg /dL definiert. Die OPS Sequenzen wurden off-line und verblindet mit einem semi-
quantitativen Verfahren basierend auf Arbeiten von Sakr (47) und de Boerma (48) 
analysiert. Der Blutfluss wurde dabei in die Kategorien „kein Fluss―, „intermittierender 
Fluss―, „stagnierender Fluss― und „kontinuierlicher Fluss― eingeordnet. Alle Blutge-
fäße, die keinen kontinuierlichen Blutfluss zeigten, wurden als pathologisch gewertet 
und der prozentuale Anteil der pathologischen Gefäße wurde ermittelt. Auch die 
Gefäßdichte der Sequenzen wurde berechnet. 
Sechzehn der untersuchten Kinder entwickelten eine Infektion. Die meisten 
Infektionen verliefen nicht schwer. Die Mikrozirkulationsdaten wurden mit einem nicht 
parametrischen Testverfahren analysiert. Die Bilder von der Ohrmuschel zeigten eine 
bessere Bildqualität und waren leichter aufzunehmen als die des Oberarms. Die Ana-
lyse der Aufnahmen am Ohr zeigten eine signifikant erhöhte Anzahl an Blutgefäßen 
mit gestörtem Blutfluss in der Gruppe der Kinder mit Infektion (Infektionsgruppe: 
32%, 95% Konfidenzintervall [19-44] vs. Kontrollgruppe: 10% [6-13]; p= 0.0003). 
Abgesehen von einer Tendenz zu einer erhöhten Rate an Gefäßen mit gestörtem 
Fluss, erreichten die Mikrozikulationsmessungen am Oberarm im Vergleich beider 
Gruppen keine statistische Signifikanz (Infektion: 19% [16-25] vs. Kontrollen: 13% 
[10-11]; p= nicht signifikant). Ein Trend zu einer geringeren funktionalen Gefäßdichte 
wurde in den Ohrsequenzen der Infektionsgruppe jedoch nicht in den Armsequenzen 
beobachtet. An beiden Messorten wurde keine statistische Signifikanz erreicht. 
Aus den Ergebnissen lässt sich schlussfolgern, dass die Ohrmuschel ein 
besserer Ort als der Arm ist um Mikrozirkulationsmessungen an reifen Neugebore-
nen durchzuführen. Sogar in Neugeborenen mit leichten Infektionszeichen ist der 
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mikrozirkulatorische Blutfluss in einem Grossteil der Gefäße früh im Krankheits-
verlauf gestört. Da diese Veränderungen an der Ohrmuschel leicht erkannt werden 
können, könnte die online-Evaluation der Mikrozirkulation in Zukunft ein wichtiges 
Skreeningverfahren für Infektionen werden. 
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L.  Addendum 
 
L. 1 Patient Information Brochure 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liebe Eltern, 
 
wir dürfen Ihnen ganz herzlich zu Ihrem Nachwuchs gratulieren. 
Wie Sie bereits im Gespräch mit uns erfahren haben, führen wir 
derzeit eine Untersuchung zur Früherkennung von Infektionen bei 
Neugeborenen durch. Mit dieser Broschüre möchten wir Ihnen 
weitere Informationen zur Verfügung stellen, die Sie für die 
Entscheidung über eine Teilnahme Ihres Kindes an dieser Studie 
benötigen.  
 
 
Hintergrund 
 
Bakterielle Infektionen sind eine der häufigsten Erkrankungen 
(Häufigkeit 1-3%) der Neugeborenen. Die Zeichen einer Infektion 
sind bei Neugeborenen allerdings unspezifisch, zudem finden sich 
typische Laborveränderungen oft erst mit einer gewissen 
Zeitverzögerung. Ein schnelles Erkennen der Krankheit ist jedoch 
wünschenswert, da ein früher Beginn der Therapie den 
Krankheitsverlauf entscheidend beeinflusst.  
 
 
Studie 
 
Um Infektionen bei Neugeborenen möglicherweise schneller 
erkennen zu können, möchten wir eine nicht invasive Methode 
etablieren, die Veränderungen der Hautdurchblutung bei 
 
Untersuchung der Mikrozirkulation bei 
Neugeborenen mit perinatalem Risiko für 
eine bakterielle Infektion. 
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Neugeborenen mit Infektionsrisiko erfasst. Hierbei wird eine Methode 
angewendet, die für Ihr Kind völlig unbedenklich ist. Die Messungen 
werden bei Neugeborenen mit Infektionsrisiko durchgeführt, sowie 
bei gesunden Neu-geborenen als Kontrollgruppe. 
 
 
Methode, Ablauf und Dauer der Teilnahme 
 
Wir legen Ihrem Baby einen kleinen Messfühler auf die Haut. In dem 
Messfühler befindet sich eine Lichtquelle, die normales Licht mit einer 
Wellenlänge von 550 nm aussendet und daher grün leuchtet. Die 
Lichtquelle ist so konzipiert, dass es zu keiner Erwärmung oder 
anderen Auswirkungen auf die Haut kommt. Das grüne Licht 
ermöglicht die Darstellung von Blutgefäßen direkt unter der Haut, 
indem das reflektierte Licht durch eine kleine Videokamera erfasst 
und in einem Computer analysiert wird. Dadurch kann die 
Hautdurchblutung beurteilt werden.  
 
 
 
In Abbildung 1 sehen Sie unser Messgerät. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abb.:1: Messung der Hautdurchblutung bei einem Neugeborenen 
 
Am Ende der Messung werden noch die Körpertemperatur und der 
Blutdruck Ihres Kindes gemessen. 
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Die Untersuchung wird am 1., 2. und 3. Lebenstag durchgeführt. Sie 
ist für Ihr Kind schmerzlos, ohne Risiko und dauert ungefähr 15 bis 
20 min. Sie können selbstverständlich gerne bei der Untersuchung 
anwesend sein, wenn Sie dies wünschen. Bei einer Nichtteilnahme 
an der Studie entstehen Ihnen und Ihrem Kind keinerlei Nachteile.  
 
 
Datenschutz: 
 
Nur die Ärzte der Studie haben im Rahmen der gesetzlichen 
Vorschriften Zugang zu den vertraulichen Daten, in denen Sie 
namentlich genannt sind. Diese Personen unterliegen der 
Schweigepflicht und sind zur Beachtung des Datenschutzes 
verpflichtet. Die Weitergabe der Daten im In- und Ausland erfolgt zu 
statistischen und wissenschaftlichen Zwecken, und Ihr Kind wird 
darin nicht namentlich genannt. Die Daten werden zur Auswertung 
verschlüsselt (d.h. die Daten werden ohne Namensnennung mit einer 
Nummer versehen). 
 
Die Teilnahme an der Studie ist freiwillig und Sie können 
jederzeit die Teilnahme Ihres Kindes ohne Angabe von 
Gründen und ohne Nachteile für die weitere Behandlung, 
zurückziehen.  
 
Falls Sie weitere Fragen zu dieser Studie haben, wenden Sie sich 
bitte an uns. 
 
 
 
Studienleitung: 
 
Prof. Dr. med. O. Genzel-Boroviczény 
Leiterin der Neonatologie Maistraße 
Kinderklinik und Kinderpoliklinik des Dr. v. Haunerschen Kinderspitals 
der LMU-München 
Tel.: 089-5160-4535 
 
Dr. med. S. Hiedl 
Leitender Stationsarzt der Neonatologie Maistraße 
Kinderklinik und Kinderpoliklinik des Dr. v. Haunerschen Kinderspitals 
der LMU-München 
Tel.: 089-5160-4589 
 
 
Studiendurchführung: 
 
Irene Alba-Alejandre 
Ärztin der Neonatologie Maistraße 
Kinderklinik und Kinderpoliklinik des Dr. v. Haunerschen Kinderspitals 
der LMU-München 
Tel.: 089-5160-4589 
 
 
 
Wir danken Ihnen für Ihr Interesse und wünschen Ihnen und 
Ihrem Kind alles Gute ! 
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L. 2  Consent Form 
 
 
Klinikum der Universität  
Klinik und Poliklinik für Frauenheilkunde 
und Geburtshilfe – Innenstadt  
Direktor: Prof. Dr. med. Klaus Friese 
 
Leitung der Neonatologie: 
PD Dr. med. Orsolya Genzel-Boroviczény 
 
 
München 
Kinderklinik und Poliklinik im  
Dr. von Haunerschen Kinderspital 
Direktor: Prof. Dr. med. Dietrich Reinhardt 
 
Klinikum der Universität München  Neonatologie – Innenstadt 
Maistraße 11  D-80337 München   
 
 
  
 
    
Ihr Zeichen Unser Zeichen Ansprechpartner Telefon 089-5160 4535 Telefax -4917 E-Mail genzel@med.uni-
muenchen.de 
 
 
Einwilligungserklärung 
 
 
Name des Patienten  
(in Druckbuchstaben):........................................................................ 
Geb. Datum: .......-.......-.............    
Patient Nr.:........ 
Ich erkläre mich freiwillig bereit, dass mein Kind an der klinischen Untersuchung mit 
dem Titel:  
„Untersuchung der Mikrozirkulation bei Neugeborenen mit perinatalem Risiko für eine 
bakterielle Infektion“ 
teilnimmt. 
- Ich bin durch den Arzt/ die Ärztin.................................................................in 
einem persönlichen Gespräch ausführlich und verständlich über die 
Untersuchung und den Studienablauf sowie über Wesen, Bedeutung und 
Tragweite der klinischen Untersuchung aufgeklärt worden. 
- Ich habe darüber hinaus den Text des Informationsblattes für 
Eltern/Erziehungsberechtigte und diese Einwilligung gelesen und verstanden. 
- Aufgetretene Fragen wurden mir vom Prüfarzt/-ärztin verständlich und 
ausreichend beantwortet. 
- Ich hatte ausreichend Zeit, mich zu entscheiden. 
- Ich habe das Recht, jederzeit und ohne Angabe von Gründen meine 
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3
) 
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Einwilligung zur Teilnahme meines Kindes an der Prüfung zurückzuziehen, 
ohne dass mir und meinem Kind daraus Nachteile entstehen. 
- Ich bin damit einverstanden, dass im Rahmen dieser klinischen Untersuchung 
erhobene Daten meines Kindes anonymisiert (d.h. ohne Nennung des Namens) 
aufgezeichnet werden, zur wissenschaftlichen Auswertung der klinischen 
Prüfung und zur Verwendung für weitere mit der Prüfung dieser 
Untersuchungen im Zusammenhang stehende wissenschaftlichen 
Fragenstellungen weitergegeben werden, sowie zur Überprüfung an die 
zuständigen Überwachungsbehörden oder an die Ethikkommission übermittelt 
werden.  
- Ferner erkläre ich mein Einverständnis, dass die Studienleitung und 
vorgenannte Fachleute und Beauftragte in personenbezogene Daten meines 
Kindes Einsicht nehmen. Dies dient einer vollständigen Überprüfung der 
ordnungsgemäßen Durchführung der klinischen Untersuchung. Beim Umgang 
mit personenbezogenen Daten werden die Grundsätze des Datenschutzrechtes 
beachtet. 
 
 
Datum.................................................................. 
 
 
 
 
Unterschrift des 1. Sorgeberechtigten......................................................................... 
 
 
Unterschrift des 2. Sorgeberechtigten......................................................................... 
 
 
 
 
Unterschrift des aufklärenden Prüfarztes.................................................................. 
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L.3  Table for clinical information 
 
Ethikett u. Nummer 
Geb. 
Datum………………. 
Geb.Zeit………… 
Gewicht………..      
 
        Labor 1.LT 
 
2.LT 
3.LT 
 
 Geburtanamnese      Ο Leukozyten=        
 Infektionsrisiko      Ο Neutrophile=        
Ο Blasensprung ≥18h      Ο I:T- Quotient=        
Ο Mütterliches CrP- Erhöhung      Ο Thrombozyten=        
Ο Dick grünes Fruchtwasser       Ο Hb/Hkt=        
Ο Mütterliches Fieber (≥38,5°C)      Ο IL-6=        
Ο Choriamnionitis       Ο CRP =        
Ο Procedere:      Ο Lactat=        
 Klinische Zeichen für Infektion 1.LT  2.LT 3.LT   Ο ………………………………….     
Ο Reduzierter Allgemeinzustand          Bakteriologie     
Ο Temperaturinstabilität         Ο Blutkultur vor Antibiose:     
Ο  Hämodynamischezeichen:         Ο Ohrenabstrich Bemerkungen  
 
Tachykardie (>180bpm), Hypotonie (<65mm Hg) 
grauer Hautkolorit, Rekap.Zeit >3sek,          Ο Urin         
Ο Respiratorischezeichen         Ο Liquor         
 Tachypnoe+ Stöhnungen/ Enziehung, Apnoe          Blutgasanalyse         
Ο Neurologischezeichen          BE=___ pCO2=___         
 
Tonus Störungen, niedrieger 
Fontanelle,Krämpfe….          pH=___ pO2=___         
Ο Haut          Medikamente         
 Purpura, eruption…                   
Ο Andere                 
 TOTAL               
M.  Curriculum vitae 
 
Personal data 
Name:  Irene Alba Alejandre 
Date and Place of birth:  29 March 1981 in Granada, Spain 
Marital status:  Married 
Nationality:  Spanish 
 
School Education 
1985 –1992  School Sagrado Corazón de Jesús, Granada (Spain) 
1992 –1993 Victor Mager School. Winnipeg. MB (Canada) 
1993 –1999 High school Sagrado Corazón de Jesús, Granada (Spain) 
 
Professional Education 
Oct. 1999 – Sept. 2003 Medical studies, University of Granada (Spain). 
Oct. 2003 – Jul. 2004 5th academic year, University of Lausanne (Switzerland) 
(Erasmus scholarship) 
Sept. 2004 – Feb. 2005 6th academic year, Ludwig-Maximilian University Munich 
(European „free mover Program―) 
July 2005  Final degree at the University of Granada (Spain)  
 
Doctoral Thesis 
2005 -  Frauenklinik Innenstadt, LMU Munich in the group of 
Professor Orsolya Genzel-Boroviczèny „Orthogonal 
Polarization spectral imaging (OPS) Measurements of 
Microcirculatory Changes in Term Newborns with 
Suspected Infection― 
 
Further Qualifications 
Languages  German:  Fluent in written and spoken 
English:  Fluent in written and spoken 
French:  Fluent in written and spoken 
 Spanish:  Native language 
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Practicals 
July 2001 Pediatric Orthopedia, Hospital Carlos Haya, Málaga (Spain) 
July –August 2004  Gynecology and Obstetrics, Machame Hospital, Moshi 
(Tansania) 
November 2004 Endokrinology, Medizinische Klinik Innenstadt der LMU 
February 2005  Cardiac surgery, Klinikum Großhadern der LMU  
June –August 2005 Neonatology, 1. Frauenklinik in der Maistrasse der LMU 
 
Scholarships 
2003 – 2004  ERASMUS scholarship, University of Granada (Spain) 
2005 – 2007 DAAD-La Caixa scholarship for a research project: „Microcircula-
tory changes in Newborns at risk for early onset Infection― 
 
Residency  
Since August 2007:  Residency training program for gynecology and obstetrics, 
Frauenklinik Innenstadt der LMU, Munich. 
 
Publications 
Oral presentation  
Europaediatrics 2006, European Pediatric Research Society. Barcelona, 7. –10. 
October 2006: „Microvascular Flow is compromised early in Neonatal Infection―.  
 
Selected poster presentations  
I. Alba-Alejandre, S. Hiedl, A. Bauer, F. Christ, O. Genzel-Boroviczèny, 
„Mikrozirkulatorische Veränderungen bei neonataler Infektion.―, 32. Jahrestagung 
der Gesellschaft für Neonatologie und Pädiatrische Intensivmedizin. Viena, 18 –20 
Mai 2006.  
 
I. Alba-Alejandre, S. Hiedl, O. Genzel-Boroviczèny, „Microvascular Flow is 
compromised early in Neonatal Infection.‖ 24th European Conference on 
Microcirculation. From Vascular Biology to Clinical Microcirculation. Amsterdam, 30. 
Aug.-2. Sept. 2006 
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I. Alba-Alejandre, S. Hiedl, O. Genzel-Boroviczèny, ―Microvascular flow is 
compromised early in neonatal infection‖. 23th perinatal German Congress. Berlin, 
29 Nov. -1.Dec 2007.  
 
I.Alba- Alejandre, V. Nobis, B. Heindl, F. Kainer, ―ROTEM: Hilfreich in der 
Diagnostik der Fruchtwasserembolie? — Ein Fallbericht‖. 23th perinatal German 
Congress. Berlin, 29 Nov. -1.Dec 2007.    
 
I. Alba-Alejandre, V. von Bodungen, F. Kainer, ―ROTEM – Einsatz in der 
Geburtshilfe‖. 82. Tagung der Bayerischen Gesellschaft für Gynäkologie und 
Geburtshilfe. Augsburg, 29. - 31. May 2008 .  
 
I. Alba-Alejandre, F. Kainer, K. Friese, I. Mylonas, „Hbs-Antigen Nachweis in der 
Schwangerschaft― 57th Congress from the German Gynecology and Obstetrics 
Society. Hamburg, 16-19th Sept. 2008.  
 
I. Alba-Alejandre, S. Hiedl, A. Heger, P.Hantschmann, F. Kainer, „Spontane 
postnatale Remission bei massiver intrauteriner Dilatation der Darmschlingen― 24th 
German Congress for Perinatal Medicine. Berlin, 6-9th May 2009  
 
Original Article   
I. Alba-Alejandre, F.Kainer, K. Friese, I. Mylonas, „Hbs-Antigen-Nachweis in der 
Schwangerschaft‖. Geburtshilfe und Frauenheilkunde. Heft 06, Jahrgang 69, 
Juni 2009.  
 
Munich 16 November 2009 
 
 
 
(Irene Alba Alejandre) 
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